Knowledge

Biocompatibility

Source 📝

25: 264:"Refers to the ability of a biomaterial to perform its desired function with respect to a medical therapy, without eliciting any undesirable local or systemic effects in the recipient or beneficiary of that therapy, but generating the most appropriate beneficial cellular or tissue response in that specific situation, and optimising the clinically relevant performance of that therapy". 144: 309:
In the literature, one quite often stumbles upon the adjective form, ‘biocompatible’. However, according to Williams’ definition, this does not make any sense because biocompatibility is contextual, i.e. much more than just the material itself will determine the clinical outcome of the medical device
345:
The biocompatibility of a medical device that is intentionally placed within the cardiovascular system for transient diagnostic or therapeutic purposes refers to the ability of the device to carry out its intended function within flowing blood, with minimal interaction between device and blood that
300:
All these definitions deal with materials and not with devices. This is a drawback since many medical devices are made of more than one material. Much of the pre-clinical testing of the materials is not conducted on the devices but rather the material itself. But at some stage the testing will have
358:
The biocompatibility of a scaffold or matrix for a tissue-engineering products refers to the ability to perform as a substrate that will support the appropriate cellular activity, including the facilitation of molecular and mechanical signalling systems, in order to optimise tissue regeneration,
238:
Recently Williams (again) has been trying to reevaluate the current knowledge status regarding what factors determine clinical success. Doing so notes that an implant may not always have to be positively bioactive but it must not do any harm (either locally or systemically).
234:
seems to have been mentioned for the first time in peer-review journals and meetings in 1970 by RJ Hegyeli (Amer Chem Soc Annual Meeting abstract) and CA Homsy. It took almost two decades before it began to be commonly used in scientific literature (see the graph below).
316:
Biocompatibility (or tissue compatibility) describes the ability of a material to perform with an appropriate host response when applied as intended. A biocompatible material may not be completely "inert"; in fact, the appropriateness of the host response is decisive.
336:
The biocompatibility of a long-term implantable medical device refers to the ability of the device to perform its intended function, with the desired degree of incorporation in the host, without eliciting any undesirable local or systemic effects in that
157:
in various contexts. The term refers to the ability of a material to perform with an appropriate host response in a specific situation. The ambiguity of the term reflects the ongoing development of insights into how biomaterials interact with the
189:
and repair functions in the body are so complicated it is not adequate to describe the biocompatibility of a single material in relation to a single cell type or tissue. Sometimes one hears of biocompatibility testing that is a large battery of
258:"Comparison of the tissue response produced through the close association of the implanted candidate material to its implant site within the host animal to that tissue response recognised and established as suitable with control materials" - 325:
The scope of the first definition is so wide that D Williams tried to find suitable subgroups of applications in order to be able to make more narrow definitions. In the MDT article from 2003 the chosen supgroups and their definitions were:
277:
The Dorland Medical definition not recommended according to Williams Dictionary since it only defines biocompatibility as the absence of host response and does not include any desired or positive interactions between the host tissue and the
363:
In these definitions the notion of biocompatibility is related to devices rather than to materials as compared to top three definitions. There was a consensus conference on biomaterial definitions in Sorrento September 15–16, 2005.
198:(or other similar standards) to determine if a certain material (or rather biomedical product) is biocompatible. These tests do not determine the biocompatibility of a material, but they constitute an important step towards the 591:
Reshetov, I. V.; Starceva, O. I.; Istranov, A. L.; Vorona, B. N.; Lyundup, A. V.; Gulyaev, I. V.; Melnikov, D. V.; Shtansky, D. V.; Sheveyko, A. N. (2016). "Three-dimensional biocompatible matrix for reconstructive surgery".
295:
The fourth is an expansion or rather more precise version of the first definition noting both that low toxicity and the one should be aware of the different demands between various medical applications of the same
843:
Nowosielski R., Cesarz-Andraczke K., Sakiewicz P., Maciej A., Jakóbik-Kolon A., Babilas R., Corrosion of biocompatible Mg66+XZn30-XCa4 (X=0.2) bulk metallic glasses, Arch. Metall. Mater. 2016 vol. 61 iss. 2, s.
565: 310:
of which the biomaterial is a part. This also points to one of the weaknesses with the current definition because a medical device usually is made of more than one material.
548: 313:
Metallic glasses based on magnesium with zinc and calcium addition are tested as the potential biocompatible metallic biomaterials for biodegradable medical implants
222:
testing of biomaterials, "the authors should carefully specify the conditions of the test and comparison of different studies should be carried out with caution".
569: 122: 267:"Biocompatibility is the capability of a prosthesis implanted in the body to exist in harmony with tissue without causing deleterious changes". 459: 182:
are often made of more than one material so it might not always be sufficient to talk about the biocompatibility of a specific material.
359:
without eliciting any undesirable effects in those cells, or inducing any undesirable local or systemic responses in the eventual host.
545: 301:
to include the device since the shape, geometry and surface treatment etc. of the device will also affect its biocompatibility.
531: 89: 61: 637:"Test conditions can significantly affect the results of in vitro cytotoxicity testing of degradable metallic biomaterials" 346:
adversely affects device performance, and without inducing uncontrolled activation of cellular or plasma protein cascades.
255:"The ability of a material to perform with an appropriate host response in a specific application", Williams' definition. 68: 403: 793: 520: 292:
is not recommended according to Williams Dictionary since it only refers to local tissue responses, in animal models.
282: 108: 42: 864: 75: 773: 46: 57: 467: 408: 492: 285:
Consensus Conference I and can more easily be found in ‘The Williams Dictionary of Biomaterials’.
35: 132:: Ability of a material to perform with an appropriate host response in a specific application. 398: 373: 281:
This is also called the “Williams definition” or “William’s definition”. It was defined in the
853:
SCHMALZ, G; ARENHOLT-BINDSLEV, D. Biocompatibility of Dental Mterials. Germany: Springer, 2009
82: 886: 648: 601: 215: 206:
that will determine the biocompatibility of the material in a given application, and thus
8: 652: 605: 566:"Biocompatibility Safety Assessment of Medical Devices: FDA/ISO and Japanese Guidelines" 751: 700:
Homsy, Charles (1970). "Bio-Compatibility in selection of materials for implantation".
677: 636: 635:
Jablonská, Eva; Kubásek, Jiří; Vojtěch, Dalibor; Ruml, Tomáš; Lipov, Jan (2021-03-23).
484: 393: 352: 331: 211: 826: 789: 755: 717: 682: 664: 617: 516: 143: 138:: Ability to be in contact with a living system without producing an adverse effect. 488: 891: 747: 709: 672: 656: 609: 476: 460:"Terminology for biorelated polymers and applications (IUPAC Recommendations 2012)" 868: 552: 186: 171: 660: 383: 207: 203: 199: 163: 880: 668: 621: 480: 830: 759: 686: 219: 154: 721: 713: 162:
and eventually how those interactions determine the clinical success of a
817:
Williams, D (Oct 2003). "Revisiting the definition of biocompatibility".
378: 536:, Kammula and Morris, Medical Device & Diagnostic Industry, May 2001 862: 546:“In Vitro Biocompatibility Testing of Biomaterials and Medical Devices” 179: 159: 807:, E. L. Becker, S. I. Landau, & A. Manuila, 1986, New York: Wiley. 613: 533:
Considerations for the Biocompatibility Evaluation of Medical Devices
432:
The more general definition could be adopted by the biomedical field.
388: 195: 167: 738:
Williams, David F. (2008). "On the mechanisms of biocompatibility".
24: 191: 218:. Research results have concluded that during performing in vitro 590: 249: 175: 515:"Biological Performance of Materials", Jonathan Black,2006, 634: 289: 259: 271: 242: 49:. Unsourced material may be challenged and removed. 555:, U. Muller, Medical Device Technology, March 2008 342:Biocompatibility of short-term implantable devices 878: 805:International dictionary of medicine and biology 733: 731: 728: 320: 252:or injurious effects on biological systems". 142: 676: 109:Learn how and when to remove this message 816: 737: 702:Journal of Biomedical Materials Research 453: 451: 449: 786:The Williams dictionary of Biomaterials 879: 272:Comments on the above five definitions 699: 446: 194:test that is used in accordance with 130:Biocompatibility (biomedical therapy) 457: 243:Five definitions of biocompatibility 47:adding citations to reliable sources 18: 13: 752:10.1016/j.biomaterials.2008.04.023 404:Bovine submaxillary mucin coatings 304: 14: 903: 283:European Society for Biomaterials 16:Biologically compatible substance 568:. Mddionline.com. Archived from 23: 856: 847: 837: 810: 798: 779: 766: 34:needs additional citations for 693: 628: 584: 558: 539: 525: 509: 426: 330:Biocompatibility of long-term 178:). Modern medical devices and 153:is related to the behavior of 1: 414: 774:Dorland's Medical Dictionary 7: 367: 248:"The quality of not having 10: 908: 661:10.1038/s41598-021-85019-6 594:AIP Conference Proceedings 468:Pure and Applied Chemistry 225: 867:February 6, 2005, at the 819:Medical Device Technology 409:Titanium biocompatibility 321:Suggested sub-definitions 481:10.1351/PAC-REC-10-12-04 788:, D.F. Williams, 1999, 399:Medical grade silicone 374:Biocompatible material 147: 140: 714:10.1002/jbm.820040306 458:Vert, Michel (2012). 216:drug delivery devices 146: 127: 351:Biocompatibility of 43:improve this article 653:2021NatSR..11.6628J 606:2016AIPC.1760b0056R 572:on 29 November 2014 641:Scientific Reports 551:2015-09-24 at the 353:tissue-engineering 148: 58:"Biocompatibility" 746:(20): 2941–2953. 614:10.1063/1.4960275 332:implanted devices 119: 118: 111: 93: 899: 871: 860: 854: 851: 845: 841: 835: 834: 814: 808: 802: 796: 783: 777: 770: 764: 763: 735: 726: 725: 697: 691: 690: 680: 632: 626: 625: 588: 582: 581: 579: 577: 562: 556: 543: 537: 529: 523: 513: 507: 506: 504: 503: 497: 491:. Archived from 464: 455: 433: 430: 232:biocompatibility 151:Biocompatibility 136:Biocompatibility 114: 107: 103: 100: 94: 92: 51: 27: 19: 907: 906: 902: 901: 900: 898: 897: 896: 877: 876: 875: 874: 869:Wayback Machine 861: 857: 852: 848: 842: 838: 815: 811: 803: 799: 784: 780: 771: 767: 736: 729: 698: 694: 633: 629: 589: 585: 575: 573: 564: 563: 559: 553:Wayback Machine 544: 540: 530: 526: 514: 510: 501: 499: 495: 462: 456: 447: 437: 436: 431: 427: 417: 394:Medical implant 370: 323: 307: 305:‘Biocompatible’ 274: 245: 228: 208:medical devices 204:clinical trials 187:immune response 172:hip replacement 141: 126: 115: 104: 98: 95: 52: 50: 40: 28: 17: 12: 11: 5: 905: 895: 894: 889: 873: 872: 855: 846: 836: 809: 797: 778: 765: 727: 708:(3): 341–356. 692: 627: 583: 557: 538: 524: 508: 475:(2): 377–410. 444: 443: 442: 441: 435: 434: 424: 423: 422: 421: 416: 413: 412: 411: 406: 401: 396: 391: 386: 384:Medical device 381: 376: 369: 366: 361: 360: 356: 348: 347: 343: 339: 338: 334: 322: 319: 306: 303: 298: 297: 293: 286: 279: 273: 270: 269: 268: 265: 262: 256: 253: 244: 241: 227: 224: 200:animal testing 164:medical device 121: 120: 117: 116: 31: 29: 22: 15: 9: 6: 4: 3: 2: 904: 893: 890: 888: 885: 884: 882: 870: 866: 863: 859: 850: 840: 832: 828: 824: 820: 813: 806: 801: 795: 794:0-85323-921-5 791: 787: 782: 776: 775: 769: 761: 757: 753: 749: 745: 741: 734: 732: 723: 719: 715: 711: 707: 703: 696: 688: 684: 679: 674: 670: 666: 662: 658: 654: 650: 646: 642: 638: 631: 623: 619: 615: 611: 607: 603: 600:(1): 020056. 599: 595: 587: 571: 567: 561: 554: 550: 547: 542: 535: 534: 528: 522: 521:0-8493-3959-6 518: 512: 498:on 2015-03-19 494: 490: 486: 482: 478: 474: 470: 469: 461: 454: 452: 450: 445: 439: 438: 429: 425: 419: 418: 410: 407: 405: 402: 400: 397: 395: 392: 390: 387: 385: 382: 380: 377: 375: 372: 371: 365: 357: 354: 350: 349: 344: 341: 340: 335: 333: 329: 328: 327: 318: 314: 311: 302: 294: 291: 287: 284: 280: 278:biomaterials. 276: 275: 266: 263: 261: 257: 254: 251: 247: 246: 240: 236: 233: 223: 221: 217: 213: 209: 205: 201: 197: 193: 188: 183: 181: 177: 173: 169: 165: 161: 156: 152: 145: 139: 137: 133: 131: 124: 113: 110: 102: 99:December 2011 91: 88: 84: 81: 77: 74: 70: 67: 63: 60: –  59: 55: 54:Find sources: 48: 44: 38: 37: 32:This article 30: 26: 21: 20: 887:Biomaterials 858: 849: 839: 822: 818: 812: 804: 800: 785: 781: 772: 768: 743: 740:Biomaterials 739: 705: 701: 695: 644: 640: 630: 597: 593: 586: 574:. Retrieved 570:the original 560: 541: 532: 527: 511: 500:. Retrieved 493:the original 472: 466: 428: 362: 324: 315: 312: 308: 299: 237: 231: 229: 220:cytotoxicity 202:and finally 184: 155:biomaterials 150: 149: 135: 134: 129: 128: 105: 96: 86: 79: 72: 65: 53: 41:Please help 36:verification 33: 825:(8): 10–3. 647:(1): 6628. 576:20 November 379:Biomaterial 881:Categories 502:2013-07-28 415:References 185:Since the 180:prostheses 160:human body 125:definition 69:newspapers 669:2045-2322 622:0094-243X 420:Footnotes 389:ISO 10993 296:material. 230:The word 196:ISO 10993 168:pacemaker 166:(such as 865:Archived 844:807-810, 831:14603712 760:18440630 687:33758226 549:Archived 489:98107080 368:See also 355:products 212:implants 210:such as 192:in vitro 892:Surgery 722:5469182 678:7987994 649:Bibcode 602:Bibcode 226:History 83:scholar 829:  792:  758:  720:  685:  675:  667:  620:  519:  487:  85:  78:  71:  64:  56:  496:(PDF) 485:S2CID 463:(PDF) 440:Notes 337:host. 250:toxic 176:stent 123:IUPAC 90:JSTOR 76:books 827:PMID 790:ISBN 756:PMID 718:PMID 683:PMID 665:ISSN 618:ISSN 598:1760 578:2014 517:ISBN 290:ASTM 288:The 260:ASTM 62:news 748:doi 710:doi 673:PMC 657:doi 610:doi 477:doi 214:or 174:or 45:by 883:: 823:14 821:. 754:. 744:29 742:. 730:^ 716:. 704:. 681:. 671:. 663:. 655:. 645:11 643:. 639:. 616:. 608:. 596:. 483:. 473:84 471:. 465:. 448:^ 170:, 833:. 762:. 750:: 724:. 712:: 706:4 689:. 659:: 651:: 624:. 612:: 604:: 580:. 505:. 479:: 112:) 106:( 101:) 97:( 87:· 80:· 73:· 66:· 39:.

Index


verification
improve this article
adding citations to reliable sources
"Biocompatibility"
news
newspapers
books
scholar
JSTOR
Learn how and when to remove this message
IUPAC

biomaterials
human body
medical device
pacemaker
hip replacement
stent
prostheses
immune response
in vitro
ISO 10993
animal testing
clinical trials
medical devices
implants
drug delivery devices
cytotoxicity
toxic

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.